KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Account Payables (2020 - 2023)

Ginkgo Bioworks Holdings filings provide 4 years of Change in Account Payables readings, the most recent being -$6.7 million for Q2 2023.

  • On a quarterly basis, Change in Account Payables rose 57.14% to -$6.7 million in Q2 2023 year-over-year; TTM through Jun 2023 was -$18.5 million, a 217.66% decrease, with the full-year FY2025 number at -$3.0 million, down 162.71% from a year prior.
  • Change in Account Payables hit -$6.7 million in Q2 2023 for Ginkgo Bioworks Holdings, down from $9.7 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $26.2 million in Q1 2022 to a low of -$15.6 million in Q2 2022.
  • Median Change in Account Payables over the past 4 years was $516000.0 (2021), compared with a mean of -$525363.6.
  • The widest YoY moves for Change in Account Payables: up 4987.21% in 2022, down 2912.4% in 2022.
  • Ginkgo Bioworks Holdings' Change in Account Payables stood at $4.3 million in 2020, then tumbled by 87.87% to $524000.0 in 2021, then crashed by 2912.4% to -$14.7 million in 2022, then surged by 54.63% to -$6.7 million in 2023.
  • The last three reported values for Change in Account Payables were -$6.7 million (Q2 2023), $9.7 million (Q1 2023), and -$14.7 million (Q4 2022) per Business Quant data.